Tenax Therapeutics, Inc. (TENX) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-05-07
11:04 am
Sale
2026-04-3013GTENAX THERAPEUTICS INC PAR
TENX
T. Rowe Price Associates, Inc.2,841,114
11.000%
-110,002decrease
(-3.73%)
Filing
History
2026-05-07
10:31 am
Sale
2026-03-3113GTENAX THERAPEUTICS INC PAR
TENX
T. Rowe Price Associates, Inc.2,951,116
17.200%
-798,884decrease
(-21.30%)
Filing
History
2026-05-04
2:46 pm
Unchanged
2026-03-3113GTENAX THERAPEUTICS INC PAR
TENX
Invus Public Equities, L.P.427,141
2.500%
0
(Unchanged)
Filing
History
2026-04-08
6:26 pm
Purchase
2026-03-3113GTENAX THERAPEUTICS INC PAR
TENX
Morgan Stanley
MS
596,564
3.500%
188increase
(+0.03%)
Filing
History
2026-04-07
9:34 pm
Purchase
2026-03-3113GTENAX THERAPEUTICS INC PAR
TENX
Ikarian Capital, LLC1,145,100
6.700%
177,500increase
(+18.34%)
Filing
History
2026-03-10
6:02 pm
Purchase
2025-12-1013DTENAX THERAPEUTICS INC PAR
TENX
Giordano Christopher Thomas1,252,965
6.790%
1,252,965increase
(New Position)
Filing
History
2026-03-09
12:24 pm
Purchase
2026-02-2713GTENAX THERAPEUTICS INC PAR
TENX
Logos Global Management LP615,000
9.900%
615,000increase
(New Position)
Filing
History
2026-02-17
6:20 pm
Purchase
2025-12-3113GTENAX THERAPEUTICS INC PAR
TENX
Venrock Healthcare Capital Partners III, L.P.692,959
9.900%
139,989increase
(+25.32%)
Filing
History
2026-02-17
4:27 pm
Purchase
2025-12-3113GTENAX THERAPEUTICS INC PAR
TENX
BIOTECHNOLOGY VALUE FUND L P768,200
9.990%
427,540increase
(+125.50%)
Filing
History
2026-02-17
4:26 pm
Purchase
2025-12-3113GTENAX THERAPEUTICS INC PAR
TENX
Point72 Asset Management, L.P.423,415
6.800%
83,782increase
(+24.67%)
Filing
History
2026-02-17
4:08 pm
Unchanged
2025-12-3113GTENAX THERAPEUTICS INC PAR
TENX
Lind Global Fund II LP442,480
6.620%
0
(Unchanged)
Filing
History
2026-02-17
4:00 pm
Purchase
2025-12-3113GTENAX THERAPEUTICS INC PAR
TENX
Perceptive Advisors LLC569,308
9.100%
130,166increase
(+29.64%)
Filing
History
2026-02-17
09:55 am
Purchase
2025-12-3113GTENAX THERAPEUTICS INC PAR
TENX
Dellora Investments LP401,071
6.400%
50,000increase
(+14.24%)
Filing
History
2026-02-17
08:51 am
Purchase
2025-12-3113GTENAX THERAPEUTICS INC PAR
TENX
RTW Investments, LP650,968
9.900%
232,528increase
(+55.57%)
Filing
History
2026-02-12
1:21 pm
Purchase
2025-12-3113GTENAX THERAPEUTICS INC PAR
TENX
Morgan Stanley
MS
596,376
9.600%
596,376increase
(New Position)
Filing
History
2025-12-23
4:30 pm
Purchase
2025-12-1813GTENAX THERAPEUTICS INC PAR
TENX
Perceptive Advisors LLC439,142
7.000%
439,142increase
(New Position)
Filing
History
2025-12-08
11:46 am
Purchase
2025-11-2813GTENAX THERAPEUTICS INC PAR
TENX
Janus Henderson Group Ltd.
JHG
623,733
9.990%
457,067increase
(+274.24%)
Filing
History
2025-12-05
4:51 pm
Unchanged
2025-11-3013GTENAX THERAPEUTICS INC PAR
TENX
Ikarian Capital, LLC967,600
15.500%
0
(Unchanged)
Filing
History
2025-11-14
5:38 pm
Purchase
2025-09-3013GTENAX THERAPEUTICS INC PAR
TENX
Venrock Healthcare Capital Partners III, L.P.552,970
9.900%
103,478increase
(+23.02%)
Filing
History
2025-11-14
4:10 pm
Purchase
2025-09-3013GTENAX THERAPEUTICS INC PAR
TENX
Lind Global Fund II LP442,480
8.800%
67,480increase
(+17.99%)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, 5, Next